Local Application of Vancomycin Powder in Grade I-IIIA Open Fractures

Stopped early · Phase 4

Conditions studied: Fractures, Open, Surgical Wound Infection

In brief

The purpose of this study is to determine if local administration of vancomycin powder at the site of Grade I-IIIA open fractures at the time of surgery will be an efficacious method to lower infection rates in open fracture treatment and to elucidate any detrimental effects of applying vancomycin powder at the site of open fractures.

Key facts

Study ID

NCT02400112

Run by

University of Tennessee

People needed

11

Starts

2015-03-01

Expected to finish

2018-10-01

Last updated by the study team

2018-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Skeletally mature patients ≥18 years of age
• Acute Gustilo-Anderson Type I-IIIA open fracture
• Fracture is deemed primarily closable at initial surgery
• Likely to follow-up with surgeon until fracture is healed
• Ability to understand and agree to Informed Consent

You may not qualify if…

• Patients <18 years of age
• Gustilo-Anderson Type IIIB and IIIC open fractures
• Open fractures requiring multiple operations (i.e. for repeat surgical debridement or staged bone grafting of critical segmental defects)
• Delayed presentation of open fracture
• Pre-existing systemic infection requiring antibiotic therapy
• Allergy to Vancomycin
• Open fracture at the site of a previous fracture or surgical site
• Current skin infection, chronic wounds or known systemic infection
• Unlikely to follow-up until fracture is healed
• Unable to understand or agree to Informed Consent

Where it is running

• Erlanger Health System — Chattanooga, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.